A Review on Remdesivir: A Possible Promising Agent for the Treatment of COVID-19
Seyed MohammadReza Hashemian,1,2 Tayebeh Farhadi,2 Ali Akbar Velayati2 1Clinical Tuberculosis and Epidemiology Research Center, National Research Institute of Tuberculosis and Lung Disease (NRITLD), Shahid Beheshti University of Medical Sciences, Tehran, Iran; 2Chronic Respiratory Diseases Research...
Saved in:
Main Authors: | Hashemian SM (Author), Farhadi T (Author), Velayati AA (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Available Evidence and Ongoing Clinical Trials of Remdesivir: Could It Be a Promising Therapeutic Option for COVID-19?
by: Mekonnen Sisay
Published: (2020) -
Safety of Remdesivir and Tocilizumab in COVID-19 Treatment
by: Alexandra A. Taube, et al.
Published: (2020) -
Remdesivir-Bringing Hope for COVID-19 Treatment
by: Naser F. Al-Tannak, et al.
Published: (2020) -
Computer-aided design of amino acid-based therapeutics: a review
by: Farhadi T, et al.
Published: (2018) -
Remdesivir and the Liver: A Concise Narrative Review of Remdesivir-Associated Hepatotoxicity in Patients Hospitalized Due to COVID-19
by: Alireza FakhriRavari, et al.
Published: (2024)